North America Medical Cannabis Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Apr 2021
  • North America
  • 350 Pages
  • No of Tables: 233
  • No of Figures: 51

North America Medical Cannabis Market, By Product (Oil, Dried Medical Cannabis, Medical Cannabis Capsules, Vape Pen, Whole Flower, Creams & Moisturizer, Ground Flower, Patch, Mask & Serum, Cleanser, Others), Source (Natural, Synthetic), Species (Sativa, Hybrid, Cannabis Indica), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabigerol (CBG), Cannabinol, Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, Others), Route of Administration (Oral Solutions and Capsules, Smoking, Topicals, Vaporizers, Others), End User (Homecare Settings, Hospital and Rehab Centers, Pharmaceutical Industry, Research and Development Centers, Others), Distribution Channel (B2C, B2B), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028

North America Medical Cannabis Market

Market Analysis and Insights: North America Medical Cannabis Market 

The medical cannabis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 25.0% in the forecast period of 2021 to 2028 and is expected to reach USD 32,738.44 million by 2028. Increased medical use and legalization of cannabis is acting as a driver for the medical cannabis market.

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has wide range of applications in treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS and Alzheimer’s among others.

The increased usage of cannabis in the cosmetic products can be seen as a driver for the medical cannabis market. Complex regulatory structure for usage of cannabis is a restraint for the medical cannabis market. Novel product development with increased R & D activities may act as an opportunity for the medical cannabis market. The rise of marijuana black market is a challenge for the medical cannabis market

The medical cannabis market provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the medical cannabis market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Medical Cannabis Market

Medical Cannabis Market Scope and Market Size

The medical cannabis market is categorized into eight notable segments which are based on the product, source, species, derivatives, application, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the medical cannabis market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, mask & serum, cleanser and others. In 2021, oil segment is expected to dominate the medical cannabis market due to high technology adoption by key players in the market.
  • On the basis of source, the medical cannabis market is segmented into synthetic and natural. In 2021, synthetic segment is expected to dominate the medical cannabis market because of increasing healthcare expenditure. 
  • On the basis of species, the medical cannabis market is segmented into cannabis indica, sativa and hybrid. In 2021, cannabis indica segment is expected to dominate the medical cannabis market because of increased medicinal use of cannabis.
  • On the basis of derivatives, the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, cannabinol, cannabigerol (CBG) and others. In 2021, cannabidiol (CBD) segment is expected to dominate the medical cannabis market due to increasing demand of medical marijuana products in the market.
  • On the basis of application, the medical cannabis market is segmented into Alzheimer’s disease, appetite loss, cancer, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, arthritis, elevate mood, depression and sleep disorders, anxiety and others. In 2021, Alzheimer’s disease segment is expected to dominate the medical cannabis market because of increasing R&D activities.  
  • On the basis of route of administration, the medical cannabis market is segmented into oral solutions and capsules, smoking, vaporizers, topicals and others. In 2021, oral solutions and capsules segment is expected to dominate the medical cannabis market because of rising prevalence of chronic diseases.
  • On the basis of end user, the medical cannabis market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital and rehab centers and others. In 2021, pharmaceutical industry segment is expected to dominate the medical cannabis market because of increasing geriatric population and prevalence of chronic diseases.
  • On the basis of distribution channel, the medical cannabis market is segmented into B2B and B2C. In 2021, B2B segment is expected to dominate the medical cannabis market because of increasing demand of cannabis for medical and clinical purposes.

North America Medical Cannabis Market Country Level Analysis

North America medical cannabis market is analysed and market size information is provided by the country, product, source, species, derivatives, application, route of administration, end user and distribution channel as referenced above.

The countries covered in the North America medical cannabis market report are the U.S., Canada and Mexico.

The U.S. is dominating in the North America medical cannabis market because of the high legalization of cannabis in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

New Product Launches by Manufacturers is Creating New Opportunities for Players in the Medical Cannabis Market

The medical cannabis market also provides you with detailed market analysis for every country growth in aesthetic industry with medical cannabis market sales, impact of advancement in the medical cannabis market and changes in regulatory scenarios with their support for the medical cannabis market. The data is available for historic period 2011 to 2019. 

Competitive Landscape and Medical Cannabis Market Share Analysis

The medical cannabis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to North America medical cannabis market.

The major players operating in the North America medical cannabis market report are Tilray, Elixinol Europe Limited, Medical Marijuana, Inc., Peace Naturals Project Inc., BOL Pharma, PharmaHemp, Kiehl’s (a subsidiary of L'ORÉAL), Vermont Hemp Health, Discover Health LLC, ENDOCA, Pacific roots, CANOPY GROWTH CORPORATION, Aurora Cannabis, GW Pharmaceuticals plc, Harmony, Pure Ratios, MARY’s nutritionals, LLC, Bioactive Solutions, Inc., Upstate Elevator Supply Co., FOLIUM BIOSCIENCES, EcoGen Biosciences, Apothecanna, Zenabis Global Ltd., Cresco Labs, Greenwich Biosciences, Inc., MediPharm Labs Inc., THC Global Group Limited, Seed Cellar, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Crop King Seeds, BARNEY'S FARM and Aphria Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. 

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of medical cannabis market.

For instance, 

  • In February 2021, MediPharm Labs Inc. received the Cannabis Drug License. This was considered a milestone as MediPharm Labs will now be able to carry out manufacturing and distribution of pharmaceuticals with cannabis as their component. This will help in driving the market growth in coming years.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the medical cannabis market which also provides the benefit for organisation to improve their offering for medical cannabis market.

Customization Available: North America Medical Cannabis Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 ANNUAL COST OF CULTIVATION:

TABLE 2 ANNUAL COST OF MANUFACTURING:

TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED

TABLE 26 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 28 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY ANXIETY, BY REGION, 2021-2028 (USD MILLION)

TABLE 30 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 32 NORTH AMERICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 34 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 36 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 38 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 40 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 42 NORTH AMERICA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 44 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 46 NORTH AMERICA DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 48 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 50 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 52 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 54 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 65 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 66 NORTH AMERICA NATURAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 67 NORTH AMERICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 68 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES, 2019-2028 (USD MILLION)

TABLE 69 NORTH AMERICA SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 70 NORTH AMERICA HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 71 NORTH AMERICA CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 72 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 73 NORTH AMERICA ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 74 NORTH AMERICA SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 75 NORTH AMERICA TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 76 NORTH AMERICA VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 77 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 78 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 NORTH AMERICA HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 80 NORTH AMERICA HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 81 NORTH AMERICA REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 82 NORTH AMERICA PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 83 NORTH AMERICA RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 84 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 85 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 86 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 87 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 NORTH AMERICA B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 89 NORTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

TABLE 90 NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 91 NORTH AMERICA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 92 NORTH AMERICA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 93 NORTH AMERICA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 94 NORTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 95 NORTH AMERICA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 96 NORTH AMERICA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 97 NORTH AMERICA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 98 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 99 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 100 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 101 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 102 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 103 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 104 NORTH AMERICA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 105 NORTH AMERICA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 106 NORTH AMERICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 107 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 108 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 109 NORTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 110 NORTH AMERICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 111 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 112 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 113 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 114 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 115 NORTH AMERICA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 116 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 117 NORTH AMERICA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 118 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 119 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 120 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 121 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 122 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 123 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 124 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 125 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 126 U.S. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 127 U.S. TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 128 U.S. SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 129 U.S. SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 130 U.S. DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 131 U.S. TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 132 U.S. CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 133 U.S. SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 134 U.S. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 135 U.S. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 136 U.S. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 137 U.S. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 138 U.S. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 139 U.S. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 140 U.S. CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 141 U.S. TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 142 U.S. CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 143 U.S. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 144 U.S. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 145 U.S. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 146 U.S. MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 147 U.S. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 148 U.S. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 149 U.S. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 150 U.S. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 151 U.S. ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 152 U.S. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 153 U.S. DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 154 U.S. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 155 U.S. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 156 U.S. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 157 U.S. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 158 U.S. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 159 U.S. MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 160 U.S. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 161 U.S. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 162 CANADA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 163 CANADA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 164 CANADA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 165 CANADA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 166 CANADA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 167 CANADA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 168 CANADA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 169 CANADA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 170 CANADA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 171 CANADA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 172 CANADA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 173 CANADA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 174 CANADA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 175 CANADA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 176 CANADA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 177 CANADA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 178 CANADA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 179 CANADA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 180 CANADA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 181 CANADA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 182 CANADA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 183 CANADA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 184 CANADA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 185 CANADA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 186 CANADA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 187 CANADA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 188 CANADA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 189 CANADA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 190 CANADA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 191 CANADA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 192 CANADA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 193 CANADA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 194 CANADA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 195 CANADA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 196 CANADA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 197 CANADA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 198 MEXICO MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 199 MEXICO TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 200 MEXICO SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 201 MEXICO SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 202 MEXICO DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 203 MEXICO TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 204 MEXICO CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 205 MEXICO SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 206 MEXICO VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 207 MEXICO WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 208 MEXICO GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 209 MEXICO MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 210 MEXICO MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 211 MEXICO MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 212 MEXICO CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 213 MEXICO TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 214 MEXICO CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 215 MEXICO MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 216 MEXICO PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 217 MEXICO ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 218 MEXICO MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 219 MEXICO NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 220 MEXICO APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 221 MEXICO CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 222 MEXICO ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 223 MEXICO ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 224 MEXICO EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 225 MEXICO DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 226 MEXICO MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 227 MEXICO AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 228 MEXICO MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 229 MEXICO ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 230 MEXICO MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 231 MEXICO MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 232 MEXICO MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 233 MEXICO B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions